GS - III : Science & Technology

Comprehensive List of Item Wise Editorial Discussions of Science & Technology
 

Language: English

Instructors: Learning Space Digital

Validity Period: 120 days

₹1999 including GST

Why this course?

Description

The Item Wise Editorials from January 2021 onwards are placed in this section for the convenience of the students. This section provides the list of Editorials related to GS - III - Science & Technology.

Course Curriculum

November - 2022
476 - SANITARY NAPKINS FROM CELLULOSE … LET US CELEBRATE EVERY INNOVATION! (GS - III - SCIENCE & TECHNOLOGY) (8:00)
476 - SANITARY NAPKINS FROM CELLULOSE … LET US CELEBRATE EVERY INNOVATION!
476 - SANITARY NAPKINS FROM CELLULOSE … LET US CELEBRATE EVERY INNOVATION!
476 - SANITARY NAPKINS FROM CELLULOSE … LET US CELEBRATE EVERY INNOVATION!
465 - THE NEW DIGITAL PERSONAL DATA PROTECTION BILL, 2022 SMACKS OF SURVEILLANCE STATE! (GS - III - SCIENCE & TECHNOLOGY) (21:00)
465 - THE NEW DIGITAL PERSONAL DATA PROTECTION BILL, 2022 SMACKS OF SURVEILLANCE STATE!
465 - THE NEW DIGITAL PERSONAL DATA PROTECTION BILL, 2022 SMACKS OF SURVEILLANCE STATE!
465 - THE NEW DIGITAL PERSONAL DATA PROTECTION BILL, 2022 SMACKS OF SURVEILLANCE STATE!
434 - ARTIFICIAL HEART IS THE MOONSHOT PROJECT OF IIT K ... HOPE TO BE A GRAND SUCCESS! (GS - III - SCIENCE & TECHNOLOGY) (8:00)
434 - ARTIFICIAL HEART IS THE MOONSHOT PROJECT OF IIT K ... HOPE TO BE A GRAND SUCCESS!
434 - ARTIFICIAL HEART IS THE MOONSHOT PROJECT OF IIT K ... HOPE TO BE A GRAND SUCCESS!
434 - ARTIFICIAL HEART IS THE MOONSHOT PROJECT OF IIT K ... HOPE TO BE A GRAND SUCCESS!
431 - TO DEVELOP DEEP TECH START-UPs, WE NEED INNOVATIVE FINANCING MODELS! (GS - III - SCIENCE & TECHNOLOGY) (11:00)
431 - TO DEVELOP DEEP TECH START-UPs, WE NEED INNOVATIVE FINANCING MODELS!
431 - TO DEVELOP DEEP TECH START-UPs, WE NEED INNOVATIVE FINANCING MODELS!
431 - TO DEVELOP DEEP TECH START-UPs, WE NEED INNOVATIVE FINANCING MODELS!
430 - GREAT SILICON BATTLE IS ON … WINNING THE RACE IS NOT THAT EASY! (GS - III - SCIENCE & TECHNOLOGY) (10:00)
430 - GREAT SILICON BATTLE IS ON … WINNING THE RACE IS NOT THAT EASY!
430 - GREAT SILICON BATTLE IS ON … WINNING THE RACE IS NOT THAT EASY!
430 - GREAT SILICON BATTLE IS ON … WINNING THE RACE IS NOT THAT EASY!
October - 2022
421 - DELINEATING THE JOURNEY OF ISRO FROM PSLV TO LVM3 (GS - III - SCIENCE & TECHNOLOGY) (18:00)
421 - DELINEATING THE JOURNEY OF ISRO FROM PSLV TO LVM3
421 - DELINEATING THE JOURNEY OF ISRO FROM PSLV TO LVM3
421 - DELINEATING THE JOURNEY OF ISRO FROM PSLV TO LVM3
417 - MOOD OF THE GOVERNMENT APPEARS TO BE IN FAVOUR OF GM FOOD CROPS! (GS - III - SCIENCE & TECHNOLOGY) (28:00)
417 - MOOD OF THE GOVERNMENT APPEARS TO BE IN FAVOUR OF GM FOOD CROPS!
417 - MOOD OF THE GOVERNMENT APPEARS TO BE IN FAVOUR OF GM FOOD CROPS!
417 - MOOD OF THE GOVERNMENT APPEARS TO BE IN FAVOUR OF GM FOOD CROPS!
409 - LET US BRING EMINENT PERSONS LIKE DILIP MAHALANABIS INTO THE PUBLIC CONSCIENCE! (GS - III - SCIENCE & TECHNOLOGY) (12:00)
409 - LET US BRING EMINENT PERSONS LIKE DILIP MAHALANABIS INTO THE PUBLIC CONSCIENCE!
409 - LET US BRING EMINENT PERSONS LIKE DILIP MAHALANABIS INTO THE PUBLIC CONSCIENCE!
409 - LET US BRING EMINENT PERSONS LIKE DILIP MAHALANABIS INTO THE PUBLIC CONSCIENCE!
395 - NOBEL PHYSICS FOR QUANTUM ENTANGLEMENT & CHEMISTRY PRIZE FOR CLICK CHEMISTRY (GS - III - SCIENCE & TECHNOLOGY) (14:00)
395 - NOBEL PHYSICS FOR QUANTUM ENTANGLEMENT & CHEMISTRY PRIZE FOR CLICK CHEMISTRY
395 - NOBEL PHYSICS FOR QUANTUM ENTANGLEMENT & CHEMISTRY PRIZE FOR CLICK CHEMISTRY
395 - NOBEL PHYSICS FOR QUANTUM ENTANGLEMENT & CHEMISTRY PRIZE FOR CLICK CHEMISTRY
394 - WHY THE SMARTPHONE COMPANIES ARE RELUCTANT TO INTRODUCE NavIC ? (GS - III - SCIENCE & TECHNOLOGY) (10:00)
394 - WHY THE SMARTPHONE COMPANIES ARE RELUCTANT TO INTRODUCE NavIC
394 - WHY THE SMARTPHONE COMPANIES ARE RELUCTANT TO INTRODUCE NavIC
394 - WHY THE SMARTPHONE COMPANIES ARE RELUCTANT TO INTRODUCE NavIC
392 - LINK BETWEEN DENISOVANS, NEANDERTHALS AND MODERN HUMANS AWARDED MEDICINE NOBEL (GS - III - SCIENCE & TECHNOLOGY) (11:00)
392 - LINK BETWEEN DENISOVANS, NEANDERTHALS AND MODERN HUMANS AWARDED MEDICINE NOBEL
392 - LINK BETWEEN DENISOVANS, NEANDERTHALS AND MODERN HUMANS AWARDED MEDICINE NOBEL
392 - LINK BETWEEN DENISOVANS, NEANDERTHALS AND MODERN HUMANS AWARDED MEDICINE NOBEL
391 - ASTEROIDS, COMETS, METEORITES, NEOs, PHOs, DART, DIDYMOS, DIMORPHOS & MANY MORE! (GS - III - SCIENCE & TECHNOLOGY) (16:00)
391 - ASTEROIDS, COMETS, METEORITES, NEOs, PHOs, DART, DIDYMOS, DIMORPHOS & MANY MORE!
391 - ASTEROIDS, COMETS, METEORITES, NEOs, PHOs, DART, DIDYMOS, DIMORPHOS & MANY MORE!
391 - ASTEROIDS, COMETS, METEORITES, NEOs, PHOs, DART, DIDYMOS, DIMORPHOS & MANY MORE!
September - 2022
367 - WHAT IS RABIES? WHAT ABOUT INDIA’S ACTION PLAN TO ELIMINATE RABIES BY 2030? (GS - III - SCIENCE & TECHNOLOGY) (9:00)
367 - WHAT IS RABIES? WHAT ABOUT INDIA’S ACTION PLAN TO ELIMINATE RABIES BY 2030?
367 - WHAT IS RABIES? WHAT ABOUT INDIA’S ACTION PLAN TO ELIMINATE RABIES BY 2030?
367 - WHAT IS RABIES? WHAT ABOUT INDIA’S ACTION PLAN TO ELIMINATE RABIES BY 2030?
354 - CAN MUCOSAL VACCINES PROVIDE STERILIZING IMMUNITY … IT IS TOO EARLY TO SAY! (GS - III - SCIENCE & TECHNOLOGY) (13:00)
354 - CAN MUCOSAL VACCINES PROVIDE STERILIZING IMMUNITY … IT IS TOO EARLY TO SAY!
354 - CAN MUCOSAL VACCINES PROVIDE STERILIZING IMMUNITY … IT IS TOO EARLY TO SAY!
354 - CAN MUCOSAL VACCINES PROVIDE STERILIZING IMMUNITY … IT IS TOO EARLY TO SAY!
353 - DEHUMANIZATION IN THE ERA OF DIGITALIZATION … CASE STUDIES OF POSHAN TRACKER & MGNREGA (GS - III - SCIENCE & TECHNOLOGY) (8:00)
353 - DEHUMANIZATION IN THE ERA OF DIGITALIZATION … CASE STUDIES OF POSHAN TRACKER & MGNREGA
353 - DEHUMANIZATION IN THE ERA OF DIGITALIZATION … CASE STUDIES OF POSHAN TRACKER & MGNREGA
353 - DEHUMANIZATION IN THE ERA OF DIGITALIZATION … CASE STUDIES OF POSHAN TRACKER & MGNREGA
340 - DELINEATING THE TRAJECTORY OF TELECOM SECTOR FROM 1G TO UPCOMING 5G (GS - III - SCIENCE & TECHNOLOGY) (6:00)
340 - DELINEATING THE TRAJECTORY OF TELECOM SECTOR FROM 1G TO UPCOMING 5G
340 - DELINEATING THE TRAJECTORY OF TELECOM SECTOR FROM 1G TO UPCOMING 5G
340 - DELINEATING THE TRAJECTORY OF TELECOM SECTOR FROM 1G TO UPCOMING 5G
August - 2022
July - 2022
268 - NARROW THE GULF BETWEEN SCIENCE & SOCIETY … BRING IT IN PUBLIC IMAGINATION! (GS - III - SCIENCE & TECHNOLOGY) (8:00)
268 - NARROW THE GULF BETWEEN SCIENCE & SOCIETY … BRING IT IN PUBLIC IMAGINATION!
268 - NARROW THE GULF BETWEEN SCIENCE & SOCIETY ... BRING IT IN PUBLIC IMAGINATION!
268 - NARROW THE GULF BETWEEN SCIENCE & SOCIETY ... BRING IT IN PUBLIC IMAGINATION!
244 - IN-SPACe IN AHMEDABAD … WHAT ABOUT THE FOCUS ON SPACE-GRADE ELECTRONICS? (GS - III … SCIENCE AND TECHNOLOGY) (11:00)
244 - IN-SPACe IN AHMEDABAD … WHAT ABOUT THE FOCUS ON SPACE-GRADE ELECTRONICS?
244 - IN-SPACe IN AHMEDABAD … WHAT ABOUT THE FOCUS ON SPACE-GRADE ELECTRONICS?
244 - IN-SPACe IN AHMEDABAD … WHAT ABOUT THE FOCUS ON SPACE-GRADE ELECTRONICS?
June - 2022
May - 2022
211 - BLACK HOLE-SAGITTARIUS A, EVENT HORIZON, SUPERNOVA, INTERFEROMETRY (GS - III - SCIENCE & TECHNOLOGY) (10:00)
211 - BLACK HOLE-SAGITTARIUS A, EVENT HORIZON, SUPERNOVA, INTERFEROMETRY
211 - BLACK HOLE-SAGITTARIUS A, EVENT HORIZON, SUPERNOVA, INTERFEROMETRY
211 - BLACK HOLE-SAGITTARIUS A, EVENT HORIZON, SUPERNOVA, INTERFEROMETRY
204 - GAGAN IS FINE … BUT WHAT HAPPENED TO OUR OWN NAVIGATION, NavIC ? (GS - III - SCIENCE & TECHNOLOGY) (9:00)
204 - GAGAN IS FINE … BUT WHAT HAPPENED TO OUR OWN NAVIGATION, NavIC ?
204 - GAGAN IS FINE … BUT WHAT HAPPENED TO OUR OWN NAVIGATION, NavIC ?
204 - GAGAN IS FINE … BUT WHAT HAPPENED TO OUR OWN NAVIGATION, NavIC ?
200 - MONKEYPOX SPREAD TO EUROPE … THE REASONS ARE UNCLEAR TILL NOW! (GS - III - SCIENCE & TECHNOLOGY) (7:00)
200 - MONKEYPOX SPREAD TO EUROPE … THE REASONS ARE UNCLEAR TILL NOW!
200 - MONKEYPOX SPREAD TO EUROPE … THE REASONS ARE UNCLEAR TILL NOW!
200 - MONKEYPOX SPREAD TO EUROPE … THE REASONS ARE UNCLEAR TILL NOW!
199 - TRIAL OF GAGAN IS THE MOST AWAITED MOMENT! GAGAN ALSO HAS SEVERAL OTHER BENEFITS! (GS - III - SCIENCE & TECHNOLOGY) (13:00)
199 - TRIAL OF GAGAN IS THE MOST AWAITED MOMENT! GAGAN ALSO HAS SEVERAL OTHER BENEFITS!
199 - TRIAL OF GAGAN IS THE MOST AWAITED MOMENT! GAGAN ALSO HAS SEVERAL OTHER BENEFITS!
199 - TRIAL OF GAGAN IS THE MOST AWAITED MOMENT! GAGAN ALSO HAS SEVERAL OTHER BENEFITS!
183 - AFTER RTS, SAS01 … R21MATRIX-M IS THE SECOND MALARIA VACCINE (GS - III - SCIENCE& TECHNOLOGY) (11:00)
183 - AFTER RTS, SAS01 … R21MATRIX-M IS THE SECOND MALARIA VACCINE
183 - AFTER RTS, SAS01 … R21MATRIX-M IS THE SECOND MALARIA VACCINE
183 - AFTER RTS, SAS01 … R21MATRIX-M IS THE SECOND MALARIA VACCINE
173 - EV FIRES … DO NOT CUT THE CORNERS … MESSAGE FROM AN INDIAN ORIGIN EXPERT! (GS – III … SCIENCE & TECHNOLOGY) (14:00)
173 - EV FIRES … DO NOT CUT THE CORNERS … MESSAGE FROM AN INDIAN ORIGIN EXPERT!
173 - EV FIRES … DO NOT CUT THE CORNERS … MESSAGE FROM AN INDIAN ORIGIN EXPERT!
173 - EV FIRES … DO NOT CUT THE CORNERS … MESSAGE FROM AN INDIAN ORIGIN EXPERT!
168 - OPEN RADIO ACCESS NETWORK (O-RAN) ... WHAT ARE ITS PROS AND CONS? (GS – III … SCIENCE & TECHNOLOGY) (6:00)
168 - OPEN RADIO ACCESS NETWORK (O-RAN) ... WHAT ARE ITS PROS AND CONS
168 - OPEN RADIO ACCESS NETWORK (O-RAN) ... WHAT ARE ITS PROS AND CONS
168 - OPEN RADIO ACCESS NETWORK (O-RAN) ... WHAT ARE ITS PROS AND CONS
April - 2022
148 - SOLAR MINIMUM, SOLAR MAXIMUM, SOLAR FLARES, CORONAL MASS EJECTIONS (GS - III … SCIENCE & TECHNOLOGY) (8:00)
148 - SOLAR MINIMUM, SOLAR MAXIMUM, SOLAR FLARES, CORONAL MASS EJECTIONS
148 - SOLAR MINIMUM, SOLAR MAXIMUM, SOLAR FLARES, CORONAL MASS EJECTIONS
148 - SOLAR MINIMUM, SOLAR MAXIMUM, SOLAR FLARES, CORONAL MASS EJECTIONS
147 - DO NOT SEE IRON DEFICIENCY ANEMIA IN ISOLATION … IT IS A COMPLEX ISSUE! (GS - III … SCIENCE & TECHNOLOGY) (12:00)
147 - DO NOT SEE IRON DEFICIENCY ANEMIA IN ISOLATION … IT IS A COMPLEX ISSUE!
147 - DO NOT SEE IRON DEFICIENCY ANEMIA IN ISOLATION … IT IS A COMPLEX ISSUE!
147 - DO NOT SEE IRON DEFICIENCY ANEMIA IN ISOLATION … IT IS A COMPLEX ISSUE!
146 - SOLID STATE RESEARCH … LET US HOPE FOR THE HOME-GROWN BATTERY TECHNOLOGY FOR EVs! (GS - III … SCIENCE & TECHNOLOGY) (10:00)
146 - SOLID STATE RESEARCH … LET US HOPE FOR THE HOME-GROWN BATTERY TECHNOLOGY FOR EVs!
146 - SOLID STATE RESEARCH … LET US HOPE FOR THE HOME-GROWN BATTERY TECHNOLOGY FOR EVs!
146 - SOLID STATE RESEARCH … LET US HOPE FOR THE HOME-GROWN BATTERY TECHNOLOGY FOR EVs!
145 - WHAT DO YOU UNDERSTAND BY ELECTROMAGNETIC SPECTRUM (GS - III … SCIENCE & TECHNOLOGY) (7:00)
145 - WHAT DO YOU UNDERSTAND BY ELECTROMAGNETIC SPECTRUM
145 - WHAT DO YOU UNDERSTAND BY ELECTROMAGNETIC SPECTRUM
145 - WHAT DO YOU UNDERSTAND BY ELECTROMAGNETIC SPECTRUM
143 - SDN1, SDN2 & SDN3 … CLARITY ABOUT GENOME EDITING & GENETIC MODIFICATION (GS - III … SCIENCE & TECHNOLOGY) (8:00)
143 - SDN1, SDN2 & SDN3 … CLARITY ABOUT GENOME EDITING & GENETIC MODIFICATION
143 - SDN1, SDN2 & SDN3 … CLARITY ABOUT GENOME EDITING & GENETIC MODIFICATION
143 - SDN1, SDN2 & SDN3 … CLARITY ABOUT GENOME EDITING & GENETIC MODIFICATION
140 - PRECAUTIONARY DOSE … WHY CAN’T THE GOVERNMENT PROVIDE IT UNIVERSALLY? (GS - III … SCIENCE & TECHNOLOGY) (6:00)
140 - PRECAUTIONARY DOSE … WHY CAN’T THE GOVERNMENT PROVIDE IT UNIVERSALLY?
140 - PRECAUTIONARY DOSE... WHY CAN'T THE GOVERNMENT PROVIDE IT UNIVERSALLY?
140 - PRECAUTIONARY DOSE ... WHY CAN'T THE GOVERNMENT PROVIDE IT UNIVERSALLY?
136 - XE-RECOMBINANT VIRUS … INDIA SHOULD INCREASE CAPACITY FOR GENOME SEQUENCING! (GS – III … SCIENCE & TECHNOLOGY) (7:00)
136 - XE-RECOMBINANT VIRUS … INDIA SHOULD INCREASE CAPACITY FOR GENOME SEQUENCING!
136 - XE-RECOMBINANT VIRUS … INDIA SHOULD INCREASE CAPACITY FOR GENOME SEQUENCING!
136 - XE-RECOMBINANT VIRUS … INDIA SHOULD INCREASE CAPACITY FOR GENOME SEQUENCING!
132 - BHARAT BIOTECH IS QUITE OFTEN IN THE NEWS … IT’S REPUTATION IS AT STAKE! (GS - III … SCIENCE & TECHNOLOGY) (6:00)
132 - BHARAT BIOTECH IS QUITE OFTEN IN THE NEWS … IT’S REPUTATION IS AT STAKE!
132 - BHARAT BIOTECH IS QUITE OFTEN IN THE NEWS … IT’S REPUTATION IS AT STAKE!
132 - BHARAT BIOTECH IS QUITE OFTEN IN THE NEWS … IT’S REPUTATION IS AT STAKE!
March - 2022
105 - WAIVER OF INTELLECTUAL PROPERTY RIGHTS ON VACCINES … TOO LITTLE & TOO LATE! (GS – III … SCIENCE & TECHNOLOGY) (11:00)
105 - WAIVER OF INTELLECTUAL PROPERTY RIGHTS ON VACCINES … TOO LITTLE & TOO LATE!
105 - WAIVER OF INTELLECTUAL PROPERTY RIGHTS ON VACCINES … TOO LITTLE & TOO LATE!
105 - WAIVER OF INTELLECTUAL PROPERTY RIGHTS ON VACCINES … TOO LITTLE & TOO LATE!
100 - STEM CELLS, HUMAN BODY’S RAW MATERIALS, HERALDS HUGE PROMISE & INTEREST! (GS-III … SCIENCE & TECHNOLOGY) (10:00)
100 - STEM CELLS, HUMAN BODY’S RAW MATERIALS, HERALDS HUGE PROMISE & INTEREST!
100 - STEM CELLS, HUMAN BODY’S RAW MATERIALS, HERALDS HUGE PROMISE & INTEREST!
100 - STEM CELLS, HUMAN BODY’S RAW MATERIALS, HERALDS HUGE PROMISE & INTEREST!
99 - WHY COVID-19 IS MILD IN SOME … SEVERE IN OTHERS? …genoMICC HAS THE ANSWER! (GS-III … SCIENCE & TECHNOLOGY) (8:00)
99 - WHY COVID-19 IS MILD IN SOME … SEVERE IN OTHERS? …GENOMICC HAS THE ANSWER!
99 - WHY COVID-19 IS MILD IN SOME … SEVERE IN OTHERS? …GENOMICC HAS THE ANSWER!
99 - WHY COVID-19 IS MILD IN SOME … SEVERE IN OTHERS? …GENOMICC HAS THE ANSWER!
98 - WHY THE INTERNATIONAL SPACE STATION REQUIRES FREQUENT MANEUVERING? (GS-III … SCIENCE & TECHNOLOGY) (8:00)
98 - WHY THE INTERNATIONAL SPACE STATION REQUIRES FREQUENT MANEUVERING?
98 - WHY THE INTERNATIONAL SPACE STATION REQUIRES FREQUENT MANEUVERING?
98 - WHY THE INTERNATIONAL SPACE STATION REQUIRES FREQUENT MANEUVERING?
92 - A GLANCE AT INDIA’S FIRST MRNA VACCINE! (GS-III - SCIENCE & TECHNOLOGY) (8:00)
92 - A GLANCE AT INDIA’S FIRST MRNA VACCINE!
92 - A GLANCE AT INDIA’S FIRST MRNA VACCINE!
92 - A GLANCE AT INDIA’S FIRST MRNA VACCINE!
February - 2022
66 - NATIONAL POLICY ON SYNTHETIC BIOLOGY ... WHAT DO YOU UNDERSTAND BY IT? (GS -III ... SCIENCE & TECHNOLOGY) (7:00)
66 - NATIONAL POLICY ON SYNTHETIC BIOLOGY ... WHAT DO YOU UNDERSTAND BY IT?
66 - NATIONAL POLICY ON SYNTHETIC BIOLOGY ... WHAT DO YOU UNDERSTAND BY IT?
66 - NATIONAL POLICY ON SYNTHETIC BIOLOGY ... WHAT DO YOU UNDERSTAND BY IT?
52 - NUCLEAR FUSION ... CAN IT BECOME A PANACEA TO THE WOES OF CLIMATE CHANGE? (GS – III … SCIENCE & TECHNOLOGY) (10:00)
52 - NUCLEAR FUSION ... CAN IT BECOME A PANACEA TO THE WOES OF CLIMATE CHANGE?
52 - NUCLEAR FUSION ... CAN IT BECOME A PANACEA TO THE WOES OF CLIMATE CHANGE?
52 - NUCLEAR FUSION ... CAN IT BECOME A PANACEA TO THE WOES OF CLIMATE CHANGE?
35 - DO WE NEED TO REALLY WORRY ABOUT THE NEW CORONAVIRUS NEOCOV? (GS-III … SCIENCE & TECHNOLOGY) (7:00)
35 - DO WE NEED TO REALLY WORRY ABOUT THE NEW CORONAVIRUS NEOCOV?
35 - DO WE NEED TO REALLY WORRY ABOUT THE NEW CORONAVIRUS NEOCOV?
35 - DO WE NEED TO REALLY WORRY ABOUT THE NEW CORONAVIRUS NEOCOV?
34 - TWO IMPORTANT DIMENSIONS OF ANTRIX-DEVAS DEAL … WHAT IS THE MESSAGE TO GOI? (GS-III … SCIENCE & TECHNOLOGY) (12:00)
34 - TWO IMPORTANT DIMENSIONS OF ANTRIX-DEVAS DEAL … WHAT IS THE MESSAGE TO GOI?
34 - TWO IMPORTANT DIMENSIONS OF ANTRIX-DEVAS DEAL … WHAT IS THE MESSAGE TO GOI?
34 - TWO IMPORTANT DIMENSIONS OF ANTRIX-DEVAS DEAL … WHAT IS THE MESSAGE TO GOI?
January - 2022
25 - XENOTRANSPLANTATION … A GOOD BEGINNING, BUT MANY UNKNOWNS PERSIST! (GS-III … SCIENCE & TECHNOLOGY) (8:00)
25 - XENOTRANSPLANTATION … A GOOD BEGINNING, BUT MANY UNKNOWNS PERSIST!
25 - XENOTRANSPLANTATION … A GOOD BEGINNING, BUT MANY UNKNOWNS PERSIST!
25 - XENOTRANSPLANTATION … A GOOD BEGINNING, BUT MANY UNKNOWNS PERSIST!
22 - NFTs ARE IN A REGULATORY BLIND SPOT RAISES MORE QUESTIONS THAN ANSWERS! (GS – III … SCIENCE & TECHNOLOGY) (8:00)
22 - NFTs ARE IN A REGULATORY BLIND SPOT RAISES MORE QUESTIONS THAN ANSWERS!
22 - NFTs ARE IN A REGULATORY BLIND SPOT RAISES MORE QUESTIONS THAN ANSWERS!
22 - NFTs ARE IN A REGULATORY BLIND SPOT RAISES MORE QUESTIONS THAN ANSWERS!
6 - WHAT IS INSACOG? WHY THE GENOME SEQUENCING IS LOW IN INDIA? (GS – III … SCIENCE & TECHNOLOGY) (8:00)
6 - WHAT IS INSACOG? WHY THE GENOME SEQUENCING IS LOW IN INDIA?
6 - WHAT IS INSACOG? WHY THE GENOME SEQUENCING IS LOW IN INDIA?
6 - WHAT IS INSACOG? WHY THE GENOME SEQUENCING IS LOW IN INDIA?
1 - CORBEVAX, COVOVAX, MOLNUPIRAVIR AND MUCH MORE ABOUT COVID-19 (GS – III … SCIENCE & TECHNOLOGY) (19:00)
1 - CORBEVAX, COVOVAX, MOLNUPIRAVIR AND MUCH MORE ABOUT COVID-19
1 - CORBEVAX, COVOVAX, MOLNUPIRAVIR AND MUCH MORE ABOUT COVID-19
1 - CORBEVAX, COVOVAX, MOLNUPIRAVIR AND MUCH MORE ABOUT COVID-19
December - 2021
252 - WHAT IS SO SPECIAL ABOUT THE JAMES WEBB SPACE TELESCOPE? (GS III - SCIENCE & TECHNOLOGY) (12:00)
252 - WHAT IS SO SPECIAL ABOUT THE JAMES WEBB SPACE TELESCOPE?
252 - WHAT IS SO SPECIAL ABOUT THE JAMES WEBB SPACE TELESCOPE?
252 - WHAT IS SO SPECIAL ABOUT THE JAMES WEBB SPACE TELESCOPE?
November - 2021
188 - ANTI SATELLITE TEST BY RUSSIA … UN AS USUAL NOT SERIOUS ABOUT SUCH THINGS! (GS – III … SCIENCE & TECHNOLOGY) (10:00)
188 - ANTI SATELLITE TEST BY RUSSIA … UN AS USUAL NOT SERIOUS ABOUT SUCH THINGS!
188 - ANTI SATELLITE TEST BY RUSSIA … UN AS USUAL NOT SERIOUS ABOUT SUCH THINGS!
188 - ANTI SATELLITE TEST BY RUSSIA … UN AS USUAL NOT SERIOUS ABOUT SUCH THINGS!
168 - IDENTIFYING SOLAR FLARES … INDIA’S SCIENTIFIC PROWESS! (GS – III … SCIENCE & TECHNOLOGY) (5:00)
168 - IDENTIFYING SOLAR FLARES … INDIA’S SCIENTIFIC PROWESS!
168 - IDENTIFYING SOLAR FLARES … INDIA’S SCIENTIFIC PROWESS!
168 - IDENTIFYING SOLAR FLARES … INDIA’S SCIENTIFIC PROWESS!
161 - AN INSIGHT INTO NOBEL PRIZES 2021 (GS – III – SCIENCE & TECHNOLOGY) (14:00)
161 - AN INSIGHT INTO NOBEL PRIZES 2021
161 - AN INSIGHT INTO NOBEL PRIZES 2021
161 - AN INSIGHT INTO NOBEL PRIZES 2021
159 - 100 CRORE VACCINES … KEY INGREDIENTS OF INDIA’S SUCCESS STORY! (GS – III … SCIENCE & TECHNOLOGY) (7:00)
159 - 100 CRORE VACCINES … KEY INGREDIENTS OF INDIA’S SUCCESS STORY!
159 - 100 CRORE VACCINES … KEY INGREDIENTS OF INDIA’S SUCCESS STORY!
159 - 100 CRORE VACCINES … KEY INGREDIENTS OF INDIA’S SUCCESS STORY!
October - 2021
145 - ALL ABOUT THE NEWLY DEVELOPED MALARIA VACCINE WHICH IS ELUSIVE FOR 100 YEARS! (GS – III … Science & Technology) (15:00)
145 - ALL ABOUT THE NEWLY DEVELOPED MALARIA VACCINE WHICH IS ELUSIVE FOR 100 YEARS!
145 - ALL ABOUT THE NEWLY DEVELOPED MALARIA VACCINE WHICH IS ELUSIVE FOR 100 YEARS!
145 - ALL ABOUT THE NEWLY DEVELOPED MALARIA VACCINE WHICH IS ELUSIVE FOR 100 YEARS!
September - 2021
111 - FORTIFICATION ALONE IS NOT ENOUGH … MULTI-PRONGED APPROACH IS NEED OF THE HOUR! (GS – III … SCIENCE & TECHNOLOGY) (11:00)
111 - FORTIFICATION ALONE IS NOT ENOUGH … MULTI-PRONGED APPROACH IS NEED OF THE HOUR!
111 - FORTIFICATION ALONE IS NOT ENOUGH … MULTI-PRONGED APPROACH IS NEED OF THE HOUR!
111 - FORTIFICATION ALONE IS NOT ENOUGH … MULTI-PRONGED APPROACH IS NEED OF THE HOUR!
106 - 17 VACCINES IN 18 MONTHS FOR COVID-19 … 1 VACCINE IN 100 YEARS FOR TUBERCULOSIS! (GS – III … SCIENCE & TECHNOLOGY) (16:00)
106 - 17 VACCINES IN 18 MONTHS FOR COVID-19 … 1 VACCINE IN 100 YEARS FOR TUBERCULOSIS!
106 - 17 VACCINES IN 18 MONTHS FOR COVID-19 … 1 VACCINE IN 100 YEARS FOR TUBERCULOSIS!
106 - 17 VACCINES IN 18 MONTHS FOR COVID-19 … 1 VACCINE IN 100 YEARS FOR TUBERCULOSIS!
August - 2021
July - 2022
55 - DEGREE COURSE IN ASTROLOGY … SCIENCE OR PSEUDOSCIENCE? (GS – III … SCIENCE & TECHNOLOGY) (4:00)
55 - DEGREE COURSE IN ASTROLOGY … SCIENCE OR PSEUDOSCIENCE?
55 - DEGREE COURSE IN ASTROLOGY … SCIENCE OR PSEUDOSCIENCE?
55 - DEGREE COURSE IN ASTROLOGY … SCIENCE OR PSEUDOSCIENCE?
34 - ADVANTAGES AND DISADVANTAGES OF VARIOUS COVID-19 VACCINES (GS – III … SCIENCE & TECHNOLOGY) (14:00)
34 - ADVANTAGES AND DISADVANTAGES OF VARIOUS COVID-19 VACCINES
34 - ADVANTAGES AND DISADVANTAGES OF VARIOUS COVID-19 VACCINES
34 - ADVANTAGES AND DISADVANTAGES OF VARIOUS COVID-19 VACCINES
33 - WHAT DO YOU KNOW ABOUT PLASMID DNA VACCINE? (GS – III … SCIENCE & TECHNOLOGY) (12:00)
33 - WHAT DO YOU KNOW ABOUT PLASMID DNA VACCINE?
33 - WHAT DO YOU KNOW ABOUT PLASMID DNA VACCINE?
33 - WHAT DO YOU KNOW ABOUT PLASMID DNA VACCINE?
June - 2021
21 - GENOME SEQUENCING IS SINE QUA NON FOR CONTINUED SURVEILLANCE OF COVID-19 (GS – III … SCIENCE & TECHNOLOGY) (9:00)
21 - GENOME SEQUENCING IS SINE QUA NON FOR CONTINUED SURVEILLANCE OF COVID-19
21 - GENOME SEQUENCING IS SINE QUA NON FOR CONTINUED SURVEILLANCE OF COVID-19
21 - GENOME SEQUENCING IS SINE QUA NON FOR CONTINUED SURVEILLANCE OF COVID-19
19 - HUGE TREATMENT GAP FOR MENTAL DISORDERS … ELIMINATE STIGMA (GS – III … SCIENCE & TECHNOLOGY) (9:00)
19 - HUGE TREATMENT GAP FOR MENTAL DISORDERS … ELIMINATE STIGMA
19 - HUGE TREATMENT GAP FOR MENTAL DISORDERS … ELIMINATE STIGMA
19 - HUGE TREATMENT GAP FOR MENTAL DISORDERS … ELIMINATE STIGMA
15 - mRNA TECHNOLOGY … PAINSTAKING SCIENTIFIC RESEARCH AND STRUGGLE FOR 40 YEARS! (GS – III … SCIENCE & TECHNOLOGY) (12:00)
15 - mRNA TECHNOLOGY … PAINSTAKING SCIENTIFIC RESEARCH AND STRUGGLE FOR 40 YEARS!
15 - mRNA TECHNOLOGY … PAINSTAKING SCIENTIFIC RESEARCH AND STRUGGLE FOR 40 YEARS!
15 - mRNA TECHNOLOGY … PAINSTAKING SCIENTIFIC RESEARCH AND STRUGGLE FOR 40 YEARS!
10 - GAIN OF FUNCTION (GoF) STUDIES AND THE LAB LEAK HYPOTHESIS OF SARS-CoV2 (GS – III … SCIENCE & TECHNOLOGY) (9:00)
10 - GAIN OF FUNCTION (GoF) STUDIES AND THE LAB LEAK HYPOTHESIS OF SARS-CoV2
10 - GAIN OF FUNCTION (GoF) STUDIES AND THE LAB LEAK HYPOTHESIS OF SARS-CoV2
10 - GAIN OF FUNCTION (GoF) STUDIES AND THE LAB LEAK HYPOTHESIS OF SARS-CoV2
May - 2021
468 - THOUSANDS OF SATELLITES IN LOW-EARTH ORBIT … BENEFITS AND APPREHENSIONS (GS III – SCIENCE & TECHNOLOGY) (14:00)
468 - THOUSANDS OF SATELLITES IN LOW-EARTH ORBIT … BENEFITS AND APPREHENSIONS
468 - THOUSANDS OF SATELLITES IN LOW-EARTH ORBIT … BENEFITS AND APPREHENSIONS
468 - THOUSANDS OF SATELLITES IN LOW-EARTH ORBIT … BENEFITS AND APPREHENSIONS
458 - WHAT DO YOU UNDERSTAND BY INSACOG? WHAT IS ITS SIGNIFICANCE? (GS III – SCIENCE & TECHNOLOGY) (9:00)
458 - WHAT DO YOU UNDERSTAND BY INSACOG? WHAT IS ITS SIGNIFICANCE?
458 - WHAT DO YOU UNDERSTAND BY INSACOG? WHAT IS ITS SIGNIFICANCE?
458 - WHAT DO YOU UNDERSTAND BY INSACOG? WHAT IS ITS SIGNIFICANCE?
454 - SHOW MAGNANIMITY IN GRANTING VOLUNTARY LICENCES FOR VACCINES! (GS III – SCIENCE & TECHNOLOGY) (9:00)
454 - SHOW MAGNANIMITY IN GRANTING VOLUNTARY LICENCES FOR VACCINES!
454 - SHOW MAGNANIMITY IN GRANTING VOLUNTARY LICENCES FOR VACCINES!
454 - SHOW MAGNANIMITY IN GRANTING VOLUNTARY LICENCES FOR VACCINES!
439 - VARIANT OF INTEREST & VARIANT OF CONCERN … WHAT DO THEY SIGNIFY? (GS III – SCIENCE & TECHNOLOGY) (11:00)
439 - VARIANT OF INTEREST & VARIANT OF CONCERN … WHAT DO THEY SIGNIFY?
439 - VARIANT OF INTEREST & VARIANT OF CONCERN … WHAT DO THEY SIGNIFY?
439 - VARIANT OF INTEREST & VARIANT OF CONCERN … WHAT DO THEY SIGNIFY?
435 - FIRST NON-WESTERN COUNTRY VACCINE GETS WHO NOD! (GS III – SCIENCE & TECHNOLOGY) (8:00)
435 - FIRST NON-WESTERN COUNTRY VACCINE GETS WHO NOD!
435 - FIRST NON-WESTERN COUNTRY VACCINE GETS WHO NOD!
435 - FIRST NON-WESTERN COUNTRY VACCINE GETS WHO NOD!
434 - TRIPS WAIVER… JOE BIDEN ON SAME PAGE WITH DEVELOPING WORLD! (GS III – SCIENCE & TECHNOLOGY) (12:00)
434 - TRIPS WAIVER… JOE BIDEN ON SAME PAGE WITH DEVELOPING WORLD!
434 - TRIPS WAIVER… JOE BIDEN ON SAME PAGE WITH DEVELOPING WORLD!
434 - TRIPS WAIVER… JOE BIDEN ON SAME PAGE WITH DEVELOPING WORLD!
427 - A SUNRISE GREEN HYDROGEN SECTOR … CAN INDIA GRAB THE MAMMOTH OPPORTUNITY? (GS III – SCIENCE & TECHNOLOGY) (13:00)
427 - A SUNRISE GREEN HYDROGEN SECTOR … CAN INDIA GRAB THE MAMMOTH OPPORTUNITY?
427 - A SUNRISE GREEN HYDROGEN SECTOR … CAN INDIA GRAB THE MAMMOTH OPPORTUNITY?
427 - A SUNRISE GREEN HYDROGEN SECTOR … CAN INDIA GRAB THE MAMMOTH OPPORTUNITY?
April - 2021
423 - PATENTS VS AFFORDABLE PRICE … A CONSTANT SOURCE OF TENSION IN PHARMACEUTICALS! (GS III – SCIENCE & TECHNOLOGY) (15:00)
423 - PATENTS VS AFFORDABLE PRICE … A CONSTANT SOURCE OF TENSION IN PHARMACEUTICALS!
423 - PATENTS VS AFFORDABLE PRICE … A CONSTANT SOURCE OF TENSION IN PHARMACEUTICALS!
423 - PATENTS VS AFFORDABLE PRICE … A CONSTANT SOURCE OF TENSION IN PHARMACEUTICALS!
413 - GRAND BURIAL TO INTELLECTUAL PROPERTY APPELLATE BOARD (IPAB)! (GS III – SCIENCE & TECHNOLOGY) (9:00)
413 - GRAND BURIAL TO INTELLECTUAL PROPERTY APPELLATE BOARD (IPAB)!
413 - GRAND BURIAL TO INTELLECTUAL PROPERTY APPELLATE BOARD (IPAB)!
413 - GRAND BURIAL TO INTELLECTUAL PROPERTY APPELLATE BOARD (IPAB)!
412 - ALTERNATE VIEW WITH REGARD TO THE ELECTION COMMISSION POWERS (GS III – SCIENCE & TECHNOLOGY) (20:00)
412 - ALTERNATE VIEW WITH REGARD TO THE ELECTION COMMISSION POWERS
412 - ALTERNATE VIEW WITH REGARD TO THE ELECTION COMMISSION POWERS
412 - ALTERNATE VIEW WITH REGARD TO THE ELECTION COMMISSION POWERS
March - 2021
390 - 20 YEARS FOR DRAFT HUMAN GENOME FOOTPRINT! (GS III – SCIENCE & TECHNOLOGY) (18:00)
390 - 20 YEARS FOR DRAFT HUMAN GENOME FOOTPRINT!
390 - 20 YEARS FOR DRAFT HUMAN GENOME FOOTPRINT!
390 - 20 YEARS FOR DRAFT HUMAN GENOME FOOTPRINT!
368 - FOR RESPONSIBLE AI … THE WORLD COMMUNITY SHOULD SIT TOGETHER! (GS III ... SCIENCE & TECHNOLOGY) (9:00)
368 - FOR RESPONSIBLE AI … THE WORLD COMMUNITY SHOULD SIT TOGETHER!
368 - FOR RESPONSIBLE AI … THE WORLD COMMUNITY SHOULD SIT TOGETHER!
368 - FOR RESPONSIBLE AI … THE WORLD COMMUNITY SHOULD SIT TOGETHER!
353 - CRYPTOCURRENCIES – PROS AND CONS … A CRITICAL APPRAISAL! (GS III – SCIENCE & TECHNOLOGY) (10:00)
353 - CRYPTOCURRENCIES – PROS AND CONS … A CRITICAL APPRAISAL!
353 - CRYPTOCURRENCIES – PROS AND CONS … A CRITICAL APPRAISAL!
353 - CRYPTOCURRENCIES – PROS AND CONS … A CRITICAL APPRAISAL!
February - 2021
315 - TO END SYSTEMIC DISCRIMINATION, SCIENCE NEEDS EQUITY, DIVERSITY & INCLUSION (EDI) (GS III – SCIENCE & TECHNOLOGY) (6:00)
315 - TO END SYSTEMIC DISCRIMINATION, SCIENCE NEEDS EQUITY, DIVERSITY & INCLUSION (EDI)
315 - TO END SYSTEMIC DISCRIMINATION, SCIENCE NEEDS EQUITY, DIVERSITY & INCLUSION (EDI)
315 - TO END SYSTEMIC DISCRIMINATION, SCIENCE NEEDS EQUITY, DIVERSITY & INCLUSION (EDI)
314 - AN INSIGHT INTO FIFTH SCIENCE, TECHNOLOGY, AND INNOVATION POLICY (STIP) (GS-III … SCIENCE & TECHNOLOGY) (8:00)
314 - AN INSIGHT INTO FIFTH SCIENCE, TECHNOLOGY, AND INNOVATION POLICY (STIP)
314 - AN INSIGHT INTO FIFTH SCIENCE, TECHNOLOGY, AND INNOVATION POLICY (STIP)
314 - AN INSIGHT INTO FIFTH SCIENCE, TECHNOLOGY, AND INNOVATION POLICY (STIP)
January - 2021
306 - SCIENTIFIC ATTITUDE AND SYMPATHY PROTECTS OUR TRADITIONAL SYSTEMS! (GS-III … SCIENCE & TECHNOLOGY) (7:00)
306 - SCIENTIFIC ATTITUDE AND SYMPATHY PROTECTS OUR TRADITIONAL SYSTEMS!
306 - SCIENTIFIC ATTITUDE AND SYMPATHY PROTECTS OUR TRADITIONAL SYSTEMS!
306 - SCIENTIFIC ATTITUDE AND SYMPATHY PROTECTS OUR TRADITIONAL SYSTEMS!
295 - INDIA IS NOT INNOVATING … BUT INDIANS ARE INNOVATORS! (GS-III … SCIENCE & TECHNOLOGY) (8:00)
295 - INDIA IS NOT INNOVATING … BUT INDIANS ARE INNOVATORS!
295 - INDIA IS NOT INNOVATING … BUT INDIANS ARE INNOVATORS!
295 - INDIA IS NOT INNOVATING … BUT INDIANS ARE INNOVATORS!
286 - COVISHIELD AND COVAXIN … AN INSIGHT INTO DIFFERENT TYPES OF VACCINES (GS-III … SCIENCE & TECHNOLOGY) (28:00)
286 - COVISHIELD AND COVAXIN … AN INSIGHT INTO DIFFERENT TYPES OF VACCINES
286 - COVISHIELD AND COVAXIN … AN INSIGHT INTO DIFFERENT TYPES OF VACCINES
286 - COVISHIELD AND COVAXIN … AN INSIGHT INTO DIFFERENT TYPES OF VACCINES
272 - DILUTION OF FORM 27 … IS INDIA SUCCUMBED TO THE PRESSURE OF PHARMA MNCS? (GS-III … SCIENCE & TECHNOLOGY) (10:00)
272 - DILUTION OF FORM 27 … IS INDIA SUCCUMBED TO THE PRESSURE OF PHARMA MNCS?
272 - DILUTION OF FORM 27 … IS INDIA SUCCUMBED TO THE PRESSURE OF PHARMA MNCS?
272 - DILUTION OF FORM 27 … IS INDIA SUCCUMBED TO THE PRESSURE OF PHARMA MNCS?
271 - BIG PHARMA MADE HUGE STRIDES TO SAVE LIVES … COSTS ARE THE REAL CONCERN! (GS-III … SCIENCE & TECHNOLOGY) (9:00)
271 - BIG PHARMA MADE HUGE STRIDES TO SAVE LIVES … COSTS ARE THE REAL CONCERN!
271 - BIG PHARMA MADE HUGE STRIDES TO SAVE LIVES … COSTS ARE THE REAL CONCERN!
271 - BIG PHARMA MADE HUGE STRIDES TO SAVE LIVES … COSTS ARE THE REAL CONCERN!
270 - APPROVAL OF COVISHIELD AND COVAXIN … IS IT DONE IN A HASTE? (GS-III … SCIENCE & TECHNOLOGY) (14:00)
270 - APPROVAL OF COVISHIELD AND COVAXIN … IS IT DONE IN A HASTE?
270 - APPROVAL OF COVISHIELD AND COVAXIN … IS IT DONE IN A HASTE?
270 - APPROVAL OF COVISHIELD AND COVAXIN … IS IT DONE IN A HASTE?

How to Use

After successful purchase, this item would be added to your courses.You can access your courses in the following ways :

  • From the computer, you can access your courses after successful login
  • For other devices, you can access your library using this web app through browser of your device.

Reviews

Launch your GraphyLaunch your Graphy
100K+ creators trust Graphy to teach online
Learning Space Digital 2022 Privacy policy Terms of use Contact us Refund policy